AAAAAA

   
Results: 1-22 |
Results: 22

Authors: HATLEBAKK JG ODEGAARD S
Citation: Jg. Hatlebakk et S. Odegaard, ENDOSCOPIC ULTRASOUND - A NEW LOOK AT ACHALASIA, European journal of gastroenterology & hepatology, 10(7), 1998, pp. 543-545

Authors: FOUAD YM HATLEBAKK JG KATZ PO CASTELL DO
Citation: Ym. Fouad et al., ELEVATED UPPER ESOPHAGEAL SPHINCTER (UES) PRESSURE IS ASSOCIATED WITHREFLUX LARYNGITIS, Gastroenterology, 114(4), 1998, pp. 505-505

Authors: FOUAD YM KHOURY R HATLEBAKK JG KATZ PO CASTELL DO
Citation: Ym. Fouad et al., INEFFECTIVE ESOPHAGEAL MOTILITY [IEM] IS MORE PREVALENT IN REFLUX PATIENTS WITH RESPIRATORY SYMPTOMS, Gastroenterology, 114(4), 1998, pp. 506-506

Authors: HATLEBAKK JG KATZ P KUO B CASTELL DO
Citation: Jg. Hatlebakk et al., NOCTURNAL GASTRIC-ACID BREAKTHROUGH WITH OMEPRAZOLE DAILY - DOES DOSING SCHEDULE MAKE A DIFFERENCE, Gastroenterology, 114(4), 1998, pp. 591-591

Authors: HATLEBAKK JG KATZ PO CASTELL DO
Citation: Jg. Hatlebakk et al., PROTON PUMP INHIBITORS SHOULD BE TAKEN WITH MEALS FOR OPTIMAL-CONTROLOF GASTRIC-ACIDITY, Gastroenterology, 114(4), 1998, pp. 592-592

Authors: WILHELMSEN I HATLEBAKK JG OLAFSSON S BERSTAD A
Citation: I. Wilhelmsen et al., ON DEMAND THERAPY OF REFLUX ESOPHAGITIS - A STUDY OF SYMPTOMS, PATIENT SATISFACTION, AND QUALITY-OF-LIFE, Gastroenterology, 114(4), 1998, pp. 1352-1352

Authors: OVREBO KK HATLEBAKK JG VISTE A BASSOE HH SVANES K
Citation: Kk. Ovrebo et al., GASTROESOPHAGEAL REFLUX IN MORBIDLY OBESE PATIENTS TREATED WITH GASTRIC BANDING OR VERTICAL BANDED GASTROPLASTY, Annals of surgery, 228(1), 1998, pp. 51-58

Authors: HATLEBAKK JG BERSTAD A
Citation: Jg. Hatlebakk et A. Berstad, PROGNOSTIC FACTORS FOR RELAPSE OF REFLUX ESOPHAGITIS AND SYMPTOMS DURING 12 MONTHS OF THERAPY WITH LANSOPRAZOLE, Alimentary pharmacology & therapeutics, 11(6), 1997, pp. 1093-1099

Authors: HATLEBAKK JG BERSTAD A
Citation: Jg. Hatlebakk et A. Berstad, LANSOPRAZOLE 15 AND 30 MG DAILY IN MAINTAINING HEALING AND SYMPTOM RELIEF IN PATIENTS WITH REFLUX ESOPHAGITIS, Alimentary pharmacology & therapeutics, 11(2), 1997, pp. 365-372

Authors: HATLEBAKK JG BERSTAD A
Citation: Jg. Hatlebakk et A. Berstad, ENDOSCOPIC GRADING OF REFLUX ESOPHAGITIS - WHAT OBSERVATIONS CORRELATE WITH GASTROESOPHAGEAL REFLUX, Scandinavian journal of gastroenterology, 32(8), 1997, pp. 760-765

Authors: HATLEBAKK JG JOHNSSON F VILIEN M CARLING L WETTERHUS S THOGERSEN T
Citation: Jg. Hatlebakk et al., THE EFFECT OF CISAPRIDE IN MAINTAINING SYMPTOMATIC REMISSION IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE, Scandinavian journal of gastroenterology, 32(11), 1997, pp. 1100-1106

Authors: BERSTAD AE HATLEBAKK JG MAARTMANNMOE H BERSTAD A BRANDTZAEG P
Citation: Ae. Berstad et al., HELICOBACTER-PYLORI GASTRITIS AND EPITHELIAL-CELL PROLIFERATION IN PATIENTS WITH REFLUX ESOPHAGITIS AFTER TREATMENT WITH LANSOPRAZOLE, Gut, 41(6), 1997, pp. 740-747

Authors: OLAFSSON S BERSTAD A BANG CJ COLL P TEFERA S NYSAETER G HATLEBAKK JG HAUSKEN T OLAFSSON T
Citation: S. Olafsson et al., ANTI-H-PYLORI THERAPY WITH PYLORID, METRONIDAZOLE AND OXYTETRCYCLINE SPIRAMYCINE/, Gut, 41, 1997, pp. 210-210

Authors: HATLEBAKK JG BERSTAD A
Citation: Jg. Hatlebakk et A. Berstad, PHARMACOKINETIC OPTIMIZATION IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE, Clinical pharmacokinetics, 31(5), 1996, pp. 386-406

Authors: HATLEBAKK JG BERSTAD A
Citation: Jg. Hatlebakk et A. Berstad, GASTROESOPHAGEAL REFLUX DURING 3 MONTHS OF THERAPY WITH RANITIDINE INREFLUX ESOPHAGITIS, Scandinavian journal of gastroenterology, 31(10), 1996, pp. 954-958

Authors: TEFERA S BERSTAD A BANG CJ NYSAETER G HATLEBAKK JG OLAFSSON S NESJE LB HAUSKEN T BERSTAD K HUNDAL O
Citation: S. Tefera et al., BISMUTH-BASED COMBINATION THERAPY FOR HELICOBACTER-PYLORI-ASSOCIATED PEPTIC-ULCER DISEASE (METRONIDAZOLE FOR ERADICATION, RANITIDINE FOR PAIN), The American journal of gastroenterology, 91(5), 1996, pp. 935-941

Authors: BERSTAD A BERSTAD K WILHELMSEN I HATLEBAKK JG NESJE LB HAUSKEN T
Citation: A. Berstad et al., SPIRAMYCIN IN TRIPLE THERAPY OF HELICOBACTER-PYLORI-ASSOCIATED PEPTIC-ULCER DISEASE - AN OPEN PILOT-STUDY WITH 12-MONTH FOLLOW-UP, Alimentary pharmacology & therapeutics, 9(2), 1995, pp. 197-200

Authors: BERSTAD A HATLEBAKK JG WILHELMSEN I BERSTAD K BANG CJ NYSAETER G HAUSKEN T WEBERG R NESJE LB HJARTHOLM AS
Citation: A. Berstad et al., FOLLOW-UP ON 242 PATIENTS WITH PEPTIC-ULCER DISEASE ONE-YEAR AFTER ERADICATION OF HELICOBACTER-PYLORI INFECTION, Hepato-gastroenterology, 42(5), 1995, pp. 655-659

Authors: HATLEBAKK JG NESJE LB HAUSKEN T BANG CJ BERSTAD A
Citation: Jg. Hatlebakk et al., LANSOPRAZOLE CAPSULES AND AMOXICILLIN ORAL SUSPENSION IN THE TREATMENT OF PEPTIC-ULCER DISEASE, Scandinavian journal of gastroenterology, 30(11), 1995, pp. 1053-1057

Authors: HATLEBAKK JG BERSTAD A
Citation: Jg. Hatlebakk et A. Berstad, LANSOPRAZOLE 15 MG AND 30 MG DAILY IN LONG-TERM TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, Gastroenterology, 108(4), 1995, pp. 111-111

Authors: BERSTAD A HATLEBAKK JG
Citation: A. Berstad et Jg. Hatlebakk, LANSOPRAZOLE IN THE TREATMENT OF REFLUX ESOPHAGITIS - A SURVEY OF CLINICAL-STUDIES, Alimentary pharmacology & therapeutics, 7, 1993, pp. 34-36

Authors: HATLEBAKK JG BERSTAD A
Citation: Jg. Hatlebakk et A. Berstad, THE EFFECT OF RANITIDINE ON INTRAGASTRIC ACIDITY AND GASTROESOPHAGEALREFLUX DURING 3 MONTHS OF TREATMENT FOR REFLUX ESOPHAGITIS, Gastroenterology, 104(4), 1993, pp. 97-97
Risultati: 1-22 |